Company: OSRH
Filing Date: 2025-06-23
Form Type: 424B3
Source: 0001213900-25-056351
Chunk: 44

Company: OSR Holdings, Inc.
Filing Date: 2025-06-23
Form: 424B3
Chunk 44
---
, but are not limited to, those
factors listed under the heading “Risk Factors” elsewhere in this prospectus. Should one or more of these risks or uncertainties
materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these
forward-looking statements. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new
information, future events or otherwise, except as may be required under applicable securities laws.

By their nature, forward-looking statements involve
risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. We caution
you that forward-looking statements are not guarantees of future performance and that our actual results of operations, financial condition
and liquidity, and developments in the industry in which we operate may differ materially from those made in or suggested by the forward-looking
statements contained in this prospectus. In addition, even if our results or operations, financial condition and liquidity, and developments
in the industry in which we operate are consistent with the forward-looking statements contained in this prospectus, those results or
developments may not be indicative of results or developments in subsequent periods

<div align='center'>ELOC
FINANCING</div>

As previously disclosed on the Company’s
Current Report filed on Form 8-K on February 28, 2025, on February 25, 2025, the Company entered into a common stock purchase agreement
(the “Common Stock Purchase Agreement”) and a related registration rights agreement (the “White Lion RRA”)
with White Lion GBM Innovation Fund (“White Lion”). Capitalized terms used but not defined herein shall have the meanings
ascribed to such terms in the Common Stock Purchase Agreement and/or RRA, which are attached as Exhibits 10.1 and 10.2, respectively,
to the Company’s February 25, 2025 Form 8-K.

Pursuant to the Common Stock Purchase Agreement,
following its closing and following the effective date of a resale registration statement registering the shares issuable to White Lion
in accordance with the terms of the White Lion RRA, the Company has the right, but not the obligation, to require White Lion to purchase,
from time to time, up to the lesser of (i) $78,900,000 in aggregate gross purchase price of newly issued shares of the Company’s
common stock, par value $0.0001 per share (the “Common